These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35005950)

  • 1. Polyethylene Glycol-Mediated Fusion of Extracellular Vesicles with Cationic Liposomes for the Design of Hybrid Delivery Systems.
    Mukherjee D; Paul D; Sarker S; Hasan MN; Ghosh R; Prasad SE; Vemula PK; Das R; Adhikary A; Pal SK; Rakshit T
    ACS Appl Bio Mater; 2021 Dec; 4(12):8259-8266. PubMed ID: 35005950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems.
    Piffoux M; Silva AKA; Wilhelm C; Gazeau F; Tareste D
    ACS Nano; 2018 Jul; 12(7):6830-6842. PubMed ID: 29975503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicle-liposome hybrids via membrane fusion using cell-penetrating peptide-conjugated lipids.
    Sato Y; Zhang W; Baba T; Chung UI; Teramura Y
    Regen Ther; 2024 Jun; 26():533-540. PubMed ID: 39165408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Hybrid Extracellular Vesicles by Fusion with Functionalized Liposomes.
    Piffoux M; Silva AKA; Gazeau F; Tareste D
    Methods Mol Biol; 2022; 2473():385-396. PubMed ID: 35819777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDAB cationic lipid-mPEG, PCL copolymer hybrid nano-carrier synthesis and application for delivery of siRNA targeting IGF-1R into breast cancer cells.
    Khodaei M; Rostamizadeh K; Taromchi AH; Monirinasab H; Fathi M
    Clin Transl Oncol; 2021 Jun; 23(6):1167-1178. PubMed ID: 33389648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
    Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
    Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and single-particle analysis of hybrid extracellular vesicles fused with liposomes using viral fusogenic proteins.
    Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
    FEBS Open Bio; 2022 Jun; 12(6):1178-1187. PubMed ID: 35384397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusogenic Hybrid Extracellular Vesicles with PD-1 Membrane Proteins for the Cytosolic Delivery of Cargos.
    Ishikawa R; Yoshida S; Sawada SI; Sasaki Y; Akiyoshi K
    Cancers (Basel); 2022 May; 14(11):. PubMed ID: 35681615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
    Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
    J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid extracellular vesicles for drug delivery.
    Ducrot C; Loiseau S; Wong C; Madec E; Volatron J; Piffoux M
    Cancer Lett; 2023 Apr; 558():216107. PubMed ID: 36841417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cationic lipid and polyethylene glycol enhance liposomes-mediated cell transfection and increase the fluidity of liposomes membranes].
    Yan WW; Qi XR; Wei L; Fei R; Cong X; Wang Y
    Yao Xue Xue Bao; 2003 Sep; 38(9):698-701. PubMed ID: 14730922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional siRNA Delivery by Extracellular Vesicle-Liposome Hybrid Nanoparticles.
    Evers MJW; van de Wakker SI; de Groot EM; de Jong OG; Gitz-François JJJ; Seinen CS; Sluijter JPG; Schiffelers RM; Vader P
    Adv Healthc Mater; 2022 Mar; 11(5):e2101202. PubMed ID: 34382360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
    Ho EA; Osooly M; Strutt D; Masin D; Yang Y; Yan H; Bally M
    J Pharm Sci; 2013 Jan; 102(1):227-36. PubMed ID: 23132529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Butera E; Dupont A; Aimé A; Ducarre S; Chiechio RM; Even-Hernandez P; Contino A; Maccarone G; Ravel C; Marchi V
    ACS Appl Mater Interfaces; 2024 May; 16(17):21643-21652. PubMed ID: 38625748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of soybean-derived sterylglucoside and amphipathic polyethylene glycol on the cellular delivery and anisotropy of different cationic liposomes].
    Yan W; Fei R; Wang W; Qi X; Wei L; Cong X; Wang Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 35(3):324-8. PubMed ID: 12914258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered Cancer-Derived Small Extracellular Vesicle-Liposome Hybrid Delivery System for Targeted Treatment of Breast Cancer.
    Zhang W; Ngo L; Tsao SC; Liu D; Wang Y
    ACS Appl Mater Interfaces; 2023 Apr; 15(13):16420-16433. PubMed ID: 36961985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of polyethylene glycol (PEG)-modified cationic liposome-mediated gene deliveries: effects on serum stability and transfection efficiency.
    Kim JK; Choi SH; Kim CO; Park JS; Ahn WS; Kim CK
    J Pharm Pharmacol; 2003 Apr; 55(4):453-60. PubMed ID: 12803766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.